Relationship between total cholesterol content of erythrocyte membranes and acute coronary syndrome
-
摘要: 目的:研究红细胞膜总胆固醇含量(CEM)与急性冠状动脉综合征(ACS)的相关性。方法:204例胸痛患者行冠状动脉造影后分成ACS组98例,稳定型心绞痛(SAP)组45例和对照组61例。采用酶学的方法测定各组CEM水平,用ELISA法测定血清高敏C反应蛋白(hs-CRP)水平。结果:ACS组CEM值为(149.50μg/mg,120.33~180.11μg/mg),较SAP组(79.98μg/mg,56.75~97.56μg/mg)及对照组(76.64μg/mg,62.12~91.84μg/mg)均明显增高(均P<0.05)。多因素逻辑回归分析提示CEM与ACS发病显著相关(OR 24.990,95%CI5.220~119.596,P<0.01)。CEM水平与血清hs-CRP呈显著正相关(r=0.328,P<0.01)。结论:CEM可能通过炎症反应参与ACS发病的进程,是动脉粥样易损斑块的一个潜在标记物,对于ACS的预测作用优于hs-CRP。
-
关键词:
- 急性冠状动脉综合征 /
- 红细胞膜总胆固醇含量 /
- 易损斑块 /
- 血清高敏C反应蛋白
Abstract: Objective:To study the relationship between total cholesterol content of erythrocyte membranes(CEM) and acute coronary syndrome(ACS). Method:The 204 subjects with the main complaint of chest pain underwent coronary artery angiography were divided into 3 groups,including ACS(n=98),stable angina pectoris(SAP)(n=45) and control groups(n=61).CEM levels were measured by enzymatic assay.Serum high sensitivity C-reactive protein(hs-CRP) levels were measured by ELISA. Result:CEM levels in the ACS group were significantly higher(149.50 μg/mg,range 120.33 to 180.11 μg/mg) than the SAP group(79.98 μg/mg,range 56.75 to 97.56 μg/mg) and control group(76.64 μg/mg,range 62.12 to 91.84 μg/mg).Multivariable Logistic regression analyses revealed a significant independent relation between CEM levels and ACS(OR 24.990,95%CI 5.220 to 119.596,P<0.01).We also found CEM levels were positively correlated with serum hs-CRP(r=0.328,P<0.01). Conclusion:CEM may be involved in the pathogenic progression of ACS through inflammation and is a marker of vulnerable atheromatous plaque.CEM is Superior to hs-CRP as a predictor to ACS. -
[1] TZIAKAS D N,KASKI J C,CHALIKIAS G K,etal.Total cholesterol content of erythrocyte mem-branes is increased in patients with acute coronarysyndrome:a new marker of clinical instability?[J].JAm Coll Cardiol,2007,49:2081-2089.
[2] KOLODGIE F D,BURKE A P,NAKAZAWA G,etal.Free cholesterol in atherosclerotic plaques:wheredoes it come from?[J].Current Opinion in Lipidolo-gy,2007,18:500-507.
[3] ARROYO-ESPLIGUERO R,AVANZAS P,COSIN-SALES J,et al.C-reactive protein elevation and dis-ease activity in patients with coronary artery disease[J].Eur Heart J,2004,25:401-408.
[4] BRONCEL M,CHOJNOWSKA-JEZIERSKA J,KOT-ER-MICHALAK M,et al.Erythrocyte fluidity in pa-tients with hyperlipidemia during statins therapy[J].PolArch Med Wewn,2005,113:531-537.
[5] MIWA S,INOUYE M,OHMURA C,et al.Rela-tionship between carotid atherosclerosis and erythro-cyte membrane cholesterol oxidation products in type2diabetic patients[J].Diabetes Res Clin Pract,2003,61:81-88.
[6] DE BACKER G,AMBROSIONI E,BORCH-JOHNS-EN K,et al.European guidelines on cardiovascular dis-ease prevention in clinical practice.third joint task forceof european and other societies on cardiovascular diseaseprevention in clinical practice[J].Eur Heart J,2003,24:1601-1610.
[7] PASTERKAMP G, VIRMANI R. The erythrocyte:a new player in atheromatous core formation[J]. Heart,2002,88:115-116.
[8] TABAS I. Cholesterol and phospholipid metabolism in macrophages[J]. Biochem Biophys Acta,2000,1529:164-174.
[9] ARBUSTINI E.Total erythrocyte membrane choles-terol:an innocent new marker or an active player in a-cute coronary syndromes?[J].J Am Coll Cardiol,2007,49:2090-2092.
[10] ARBUSTINI E,MORBINI P,D'ARMINI A M,etal.Plaque composition in plexogenic and thromboem-bolic pulmonary hypertension:the critical role of thethrombotic material in pultaceous core formation[J].Heart,2002,88:177-182.
[11] KOLODGIE F D, GOLD H K, BURKE A P, et al. Intraplaque hemorrhage and progression of coronary atheroma[J]. N Engl J Med,2003,349:2316-2325.
[12] LIN H L,XU X S,LU H X,et al.Pathologicalmechanisms of erythrocyte-induced vulnerability ofatherosclerotic plaques Med Hypotheses[J].Med Hy-potheses,2008,70:105-108.
计量
- 文章访问数: 66
- PDF下载数: 19
- 施引文献: 0